Posted inFeatured
AION Healthspan Launches First-in-Human Clinical Trial for REJUVXL™ Cell Therapy in Chronic Kidney Disease
An artistic rendering of AION Healthspan`s REJUVXL Cell Therapy for Chronic Kidney Disease. AION Healthspan announces enrollment for its first-in-human Phase I/II clinical trial in Diabetic Nephropathy and other forms…